Natixis Advisors, L.P. Emergent Bio Solutions Inc. Transaction History

Natixis Advisors, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$36.48 - $52.22 $1.57 Million - $2.24 Million	-42,911 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$33.11 - $55.01 $245,311 - $407,569	7,409 Added 20.87%	42,911 $1.87 Million
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $87,972 - $116,049	-1,757 Reduced 4.72%	35,502 $1.78 Million
Q2 2021 Aug 12, 2021	SELL	$56.61 - $80.46 $1.06 Million - $1.51 Million	-18,739 Reduced 33.46%	37,259 $2.35 Million
Q1 2021 May 05, 2021	SELL	$86.23 - $125.19 $830,481 - $1.21 Million	-9,631 Reduced 14.67%	55,998 $5.2 Million
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $2.07 Million - $2.91 Million	26,097 Added 66.01%	65,629 $5.88 Million
Q3 2020 Nov 12, 2020	SELL	$81.91 - $134.94 $130,154 - $214,419	-1,589 Reduced 3.86%	39,532 $4.09 Million
Q2 2020 Aug 11, 2020	SELL	$54.33 - $89.52 $622,241 - $1.03 Million	-11,453 Reduced 21.78%	41,121 $3.25 Million
Q1 2020 Apr 27, 2020	BUY	$49.34 - $68.76 $1.06 Million - $1.48 Million	21,538 Added 69.4%	52,574 $3.04 Million
Q4 2019 Feb 10, 2020	SELL	$51.21 - $59.06 $957,166 - $1.1 Million	-18,691 Reduced 37.59%	31,036 $1.67 Million
Q3 2019 Nov 12, 2019	BUY	$40.6 - $57.2 $226,426 - $319,004	5,577 Added 12.63%	49,727 $2.6 Million
Q2 2019 Aug 12, 2019	BUY	$39.92 - $53.86 $234,490 - $316,373	5,874 Added 15.35%	44,150 $2.13 Million
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $1.85 Million - $2.53 Million	38,276 New	38,276 $1.93 Million

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $429M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.